Related Experiment Video
Updated: Sep 6, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Chronic thrombosis of bioprostheses: Diagnosis and management
Jasmin H Shahinian1, Vincent Chan2, Sorin V Pislaru3
1Department of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Canada; Department of Cardiovascular Surgery, University Heart Center Freiburg, Bad Krozingen, Germany.
Insights
Bioprosthetic valve thrombosis is a growing concern, increasing despite these valves not requiring anticoagulation. This review covers diagnosis, treatment, and management strategies for this condition.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Acquired valvular heart disease leads to significant mortality and morbidity.
- Bioprosthetic valves are used in up to 90% of over 100,000 annual US valve operations.
- Prosthetic valve thrombosis incidence is rising, despite bioprosthetic valves not needing lifelong anticoagulation.
Purpose of the Study:
- To review the current diagnostic methods for bioprosthetic valve thrombosis.
- To outline treatment modalities for bioprosthetic valve thrombosis.
- To discuss the management of bioprosthetic valve thrombosis.
Main Methods:
- Literature review of current diagnostic techniques.
- Analysis of established and emerging treatment options.
- Synthesis of best practices for patient management.
Main Results:
- Bioprosthetic valve thrombosis presents a significant clinical challenge.
- Early diagnosis and appropriate management are crucial for patient outcomes.
- Treatment strategies vary based on clinical presentation and valve location.
Conclusions:
- Bioprosthetic valve thrombosis requires careful monitoring and timely intervention.
- Further research is needed to optimize diagnostic and therapeutic approaches.
- Effective management can mitigate the risks associated with bioprosthetic valve thrombosis.
Abstract:
Acquired valvular heart disease is associated with increased mortality and morbidity. While the etiology of the valvular dysfunction determines the mode of treatment, over 100,000 valve operations are performed annually in the US with the use of bioprosthetic valves comprising up to 90%. While bioprosthetic valves do not require life long anticoagulation, the incidence of prosthetic valve thrombosis is continuously increasing. This article reviews the current status on diagnosis, treatment modalities and management of bioprosthetic valve thrombosis.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care

